Effect of Tongxieyao Prescription combined with moxa stick moxibustion on diarrhea type-irritable bowel syndrome and its influence on levels of immunoglobulin and serum inflammatory factors
ZHANG Jiao1 CHEN Ting2 LIU Jing3 SHI Bin4 XING Kai5 XU Junlin1 WANG Liying1 TAO Yuan1▲
1.Department of Spleen and Stomach Diseases, Beijing Changping District Hospital of Traditional Chinese Medicine, Beijing 102200, China; 2.Department of Spleen and Stomach Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China; 3.Department of Spleen and Stomach Diseases, Yanqing Hospital, Beijing Hospital of Traditional Chinese Medicine, Beijing 102100, China; 4.Department of Nephrology, Beijing Changping District Hospital of Integrated Traditional Chinese and Western Medicine, Beijing 100096, China; 5.Department of Ophthalmology, Beijing Changping District Hospital of Traditional Chinese Medicine, Beijing 102200, China
Abstract：Objective To explore the effect of Tongxieyao Prescription combined with moxa stick moxibustion on diarrhea type-irritable bowel syndrome (IBS-D) and its influence on levels of immunoglobulin and serum inflammatory factors. Methods A total of 94 patients with IBS-D of liver depression and spleen deficiency type admitted to Department of Spleen and Stomach Diseases, Beijing Changping District Hospital of Traditional Chinese Medicine from July 2019 to October 2022 were selected and they were divided into observation group and control group according to random number table method, with 47 cases in each group. The control group was given Piverium Bromide Tablets, and the observation group was given Tongxieyao Prescription combined with moxa stick moxibustion. Both groups were treated for 14 days. Clinical efficacy, traditional Chinese medicine symptom score, irritable bowel syndrome-symptom severity scale (IBS-SSS) score, irritable bowel syndrome-quality of life (IBS-QOL) score, immunoglobulin level, inflammatory factor level of the two groups were compared, and the occurrence of adverse reactions between the two groups were recorded. Results The clinical effect of the observation group was better than that of the control group (P＜0.05). After treatment, the scores of symptoms of emotional changes cause or aggravate diarrhea, abdominal pain, pain reduction after diarrhea, hypochondriacal swelling pain, dilatation, and often sighing in two groups were lower than before treatment, and those in the observation group was lower than those in the control group (P＜0.05). After treatment, IBS-SSS scores in both groups were lower than before treatment, and that in the observation group was lower than that in the control group (P＜0.05). After treatment, IBS-QOL scores in both groups were higher than before treatment, and that in the observation group was higher than that in the control group (P＜0.05). After treatment, the levels of serum immunoglobulin(Ig)A, IgG and IgM in the two groups were lower than before treatment, and the IgA and IgG in the observation group were lower than those in the control group (P＜0.05). After treatment, the serum levels of interleukin(IL)-6 and tumor necrosis factor-α in both groups were lower than before treatment, and those in the observation group was lower than those in the control group (P＜0.05). After treatment, the serum IL-10 level in both groups was higher than that before treatment, and that in the observation group was higher than that in the control group (P＜0.05). No obvious adverse reactions were observed during treatment. Conclusion Tongxieyao Prescription combined with moxa stick moxibustion can improve the clinical efficacy of IBS-D patients, regulate immunity, control inflammation in vivo, reduce pain and improve symptoms, and is worthy of clinical application.
2023, Vol. 20 
京公网安备 11010502046598号